05 Apr 2022 Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study Member news
05 Apr 2022 Aligos Therapeutics selects drug candidate ALG-097558, a potent ritonavir-free oral protease inhibitor for the treatment and prevention of COVID-19 Member news
29 Mar 2022 eTheRNA Manufacturing announces new LNP formulation development and production service Member news
29 Mar 2022 Rejuvenate Biomed started a groundbreaking clinical trial and expands for future growth Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us